[1]汪小敏,曹林忠,宋敏,等.从痰论治激素性股骨头坏死OPG/RANK/RANKL信号调控机制研究进展[J].中国中医药信息杂志,2017,24(10):133-136.[doi:10.3969/j.issn.1005-5304.2017.10.036]
 WANG Xiao-min,CAO Lin-zhong,SONG Min,et al.Research Progress in OPG/RANK/RANKL Signal-regulated Mechanism of Steroid Induced Avascular Necrosis of Femoral Head from Phlegm Theory[J].zhongguo zhongyiyao xinxi zazhi,2017,24(10):133-136.[doi:10.3969/j.issn.1005-5304.2017.10.036]
点击复制

从痰论治激素性股骨头坏死OPG/RANK/RANKL信号调控机制研究进展

参考文献/References:

[1] 李晓敏,孔祥英,张村,等.健脾活骨方不同提取部位对骨髓间充质干细胞增殖和分化的影响[J].中国中医药信息杂志,2015,22(7):63-67.

[2] 谭旭仪,卢敏,高书图.浅析激素性股骨头坏死的“瘀、虚、痰”理论[J].中医药导报,2014,20(16):7-9.

[3] 朱辉,郑洪新,杨芳,等.补肾、健脾、活血中药对地塞米松诱导骨质疏松大鼠骨组织TRPV5表达的影响[J].中国实验方剂学杂志,2012,18(6):166-169.

[4] 刘道兵,王荣田,陈卫衡.从“痰瘀同病”论股骨头坏死的中医药治疗[J].中医杂志,2013,54(19):1644-1646.

[5] 陈卫衡.股骨头坏死“痰瘀同治”的理论基础[J].江苏中医药,2008, 40(5):3-4.

[6] 陈卫衡,周宇,何海军,等.健脾活骨方治疗早中期非创伤性股骨头坏死临床回顾性研究[J].中国中西医结合杂志,2013,33(8):1054-1058.

[7] WALSH M C, CHOI Y. Biology of the RANKL-RANK-OPG system in immunity, bone, and Beyond[J]. Frontiers in Immunology,2014(5)511.

[8] PIEDRA M, GARCIA-UNZUETA M T, BERJA A, et al. Single nucleotidepolymorphisms of the OPG/RANKL system genes in primary hyper-parathyroidism and their relationship with bone mineral density[J]. BMC Med Genet,2011,12(1):168.

[9] NELSON C A, WARREN J T, WANG M W H, et al. RANKL employs distinct binding modes to engage RANK and the OPG decoy receptor[J]. Structure (London, England?:1993),2012,20(11):1971-1982.

[10] 曹林忠,张晓刚,赵希云,等.从“虚”论治激素性股骨头坏死与OPG/RANK/RANKL系统相关性研究进展[J].中国中医药信息杂志,2017, 24(4):123-126.

[11] 赵希云,张晓刚,曹林忠,等.从脾肾论治骨质疏松症OPG/RANK/RANKL信号调控机制[J].中国骨质疏松杂志,2016,22(9):1206-1210.

[12] ZHAO J J, WU Z F, WANG L, et al. MicroRNA-145 mediates steroid-induced necrosis of the femoral head by targeting the OPG/RANK/RANKL signaling pathway[J]. PLoS One,2016,11(7):e0159805.

[13] SASAKI N, KUSANO E. Bone and bone related biochemical examinations. Bone and collagen related metabolites, measurement and clinical role of OPG[J]. Clin Calcium,2006,16(7):956-962.

[14] SCHOPPET M, PREISSNER K T, HOFBAUER L C. RANK ligand and osteoprotegerin:paracrine regulators of bone metabolism and vascular function[J]. Arterioscler Thromb Vasc Biol,2002,22(4)549-553.

[15] DAS S, SEPAHI I, DUTHIE A, et al. RANK receptor oligomerisation in the regulation of NFκB signalling[J]. Journal of Molecular Endocrinology,2014,53(1):81-91.

[16] ZHANG C, ZOU Y L, MA J, et al. Apoptosis associated with Wnt/β-catenin pathway leads to steroid-induced avascular necrosis of femoral head[J]. BMC Musculoskeletal Disorders, 2015,16:132.

[17] WEINSTEIN R S, CHEN J R, POWERS C C, et al. Promotion of osteoclast survival and antagonism of bisphosphonate induced osteoclast apoptosis by glucocorticoids[J]. J Clin Invest,2002, 109(8):1041-1048.

[18] 王建忠,王坤正,时志斌,等.长期应用糖皮质激素对大鼠股骨头骨组织OPG/RANKL mRNA表达的影响[J].西安交通大学学报:医学版,2008, 29(6):629-632.

[19] HE M, WANG J, WANG G, et al. Effect of glucocorticoids on osteoclast function in a mouse model of bone necrosis[J]. Molecular Medicine Reports,2016,14(2):1054-1060.

[20] 李屹洲,王元,陈俊宇,等.OPG/RANK/RANKL与激素性股骨头坏死易感因素的相关性研究进展[J].中国骨与关节损伤杂志,2015,30(8):892- 893.

[21] MILANOVA V, IVANOVSKA N, DIMITROVA P, et al. TLR2 elicits IL-17-mediated RANKL expression, IL-17, and OPG production in neutrophils from arthritic mice[J]. Mediators Inflamm,2014, 2014643406.

[22] CHEN S, LI J, PENG H, et al. Administration of erythropoietin exerts protective effects against glucocorticoid-induced osteonecrosis of the femoral head in rats[J]. International Journal of Molecular Medicine,2014,33(4):840-848.

[23] 刘军莲,宋剑南,雷燕,等.血脂异常及动脉粥样硬化不同痰瘀证候血浆蛋白差异表达谱的研究[J].中国中西医结合杂志,2010,30(5):482- 487.

[24] 罗详飞,徐通,江蓉星,等.从“扶正与祛邪”理论认识股骨头坏死的中医辨治[J].中国中医药信息杂志,2015,22(5):116-117.

[25] 孔祥英,万蓉,李莉,等.不同治法方药对激素性股骨头坏死鸡成骨相关因子的影响[J].中国中药杂志,2011,36(5):614-617.

[26] 陈卫衡,刘道兵,张强,等.SARS后股骨头坏死的证候特点及治疗方案优化研究(下)[J].中国中医药现代远程教育,2006,4(11):54-57.

[27] CHEN W H, KONG X Y, WAN R, et al. Effects of Huogu I formula on correlated factors of bone re-generation in chickens with steroid-induced necrosis of femoral head[J]. Chin J Inter Med, 2012,18(5):378-384.

[28] 田能,孔祥英,万蓉,等.健脾活血方对激素性股骨头坏死血管内皮生长因子表达的影响[J].中国实验方剂学杂志,2010,16(2):48-51.

[29] 陈镇秋,何伟,魏秋实,等.祛痰逐瘀法对激素性股骨头坏死兔骨髓基质干细胞生物活性的影响[J].中华中医药杂志,2016,31(7):2732- 2735.

[30] 谭旭仪.补肾、活血、祛痰三种中医治法在激素性股骨头坏死中的作用机理探讨[D].长沙:湖南中医药大学,2015.

[31] 万蓉,李莉,孔祥英,等.不同治法方药对激素性股骨头坏死鸡股骨头OPG,RANKL mRNA表达的影响[J].中国实验方剂学杂志,2011,17(8):149- 153.

[32] 闻莉,叶勇,刘松林,等.化痰活血方拆方对高脂血症大鼠血脂代谢的影响[J].中医药管理杂志,2007,15(2):130-132.

[33] 唐春萍,江涛,郭姣,等.复方贞术调脂胶囊对兔动脉粥样硬化模型脂质代谢的影响[J].中药材,2010,33(8):1285-1289.

[34] 张俐,曾勤,李楠.活血化瘀汤影响成骨细胞功能的实验研究[J].中国中医骨伤科杂志,2004,12(1):1-4.

相似文献/References:

[1]曹林忠,张晓刚,赵希云,等.从“虚”论治激素性股骨头坏死与OPG/RANK/RANKL系统相关性研究进展[J].中国中医药信息杂志,2017,24(4):123.[doi:10.3969/j.issn.1005-5304.2017.04.034]
 CAO Lin-zhong,ZHANG Xiao-gang,ZHAO Xi-yun,et al.Research Progress in Relationship Between Treating Steroid-induced Osteonecrosis of Femoral Head by Deficiency and OPG/RANK/RANKL[J].zhongguo zhongyiyao xinxi zazhi,2017,24(10):123.[doi:10.3969/j.issn.1005-5304.2017.04.034]
[2]曹盼举,张晓刚,曹林忠,等.从OPG/RANK/RANKL信号调控机制探讨从瘀论治非创伤性股骨头坏死[J].中国中医药信息杂志,2020,27(4):4.[doi:10.3969/j.issn.1005-5304.201812070]
 CAO Panju,ZHANG Xiaogang,CAO Linzhong,et al.Discussion on Treating Nontraumatic Osteonecrosis of Femoral Head from Blood Stasis Based on OPG/RANK/RANKL Signal Regulation Mechanism[J].zhongguo zhongyiyao xinxi zazhi,2020,27(10):4.[doi:10.3969/j.issn.1005-5304.201812070]
[3]宋敏,王凯,文皓楠,等.基于“脾主肉,肾主骨”理论探讨OPG/RANK/RANKL信号通路与老年性骨质疏松的相关性[J].中国中医药信息杂志,2020,27(5):1.[doi:10.3969/j.issn.1005-5304.201901029]
 SONG Min,WANG Kai,WEN Haonan,et al.Correlation Between OPG/RANK/RANKL Signaling Pathway and Senile Osteoporosis Based on the Theory of Spleen Governing Muscle and Kidney Dominating Bone[J].zhongguo zhongyiyao xinxi zazhi,2020,27(10):1.[doi:10.3969/j.issn.1005-5304.201901029]

备注/Memo

基金项目:甘肃省自然科学基金(1308RJZA293);甘肃省卫生行业科研管理项目(GWGL2014-65);甘肃中医药大学中青年基金(ZQ2014-13)

更新日期/Last Update:

2017-09-18